In Focus delivers deeper coverage of the political, cultural, and ideological issues shaping America. Published daily by senior writers and experts, these in-depth pieces go beyond the headlines to give readers the full picture. You can find our full list of In Focus pieces here .

The Wall Street Journal reported in August that fat activists, people who advocate to eliminate the social stigmas faced by fat people, are attacking Ozempic , the anti-obesity drug, for fueling the perception that fatness is a disorder instead of a harmless difference.

Recommended Stories

The Democrats who absolutely will not be president

China-Russia-North Korea axis isn't a military alliance

The GOP's overconfidence problem cracks the door open for Democrats

It sounds crazy because it is. But

See Full Page